Effects of asbestiform antigorite on human alveolar epithelial A549 cells: A morphological and immunohistochemical study

Acta Histochemica

Volumn 112, Issue 2, 2010, Pages 133-146

  Pugnaloni, Armanda ^a   Giantomassi, Federica ^a   Lucarini, Guendalina ^a   Capella, Silvana ^b,c   Belmonte, Monica Mattioli ^a   Orciani, Monia ^a   Belluso, Elena ^b,c  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c CNR   (Italy)

Author keywords

A549 cells; Asbestiform antigorite; Cell activation; Immunohistochemistry; Mineral fibres; Ultrastructure

Indexed keywords

ACTIN; ASBESTIFORM ANTIGORITE; BETA CATENIN; CHRYSOTILE; MINERAL FIBER; PHALLOIDIN; PROTEIN CDC42; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CANCER CELL CULTURE; CANCER RISK; CARCINOGENESIS; CELL ACTIVATION; CELL DAMAGE; CELL FUNCTION; CELL MOTILITY; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE COURSE; ENVIRONMENTAL EXPOSURE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; PROTEIN SYNTHESIS; SCANNING TRANSMISSION ELECTRON MICROSCOPY; SPECTROMETRY; X RAY DIFFRACTION;

ASBESTOS, SERPENTINE; BETA CATENIN; CDC42 GTP-BINDING PROTEIN; CELL LINE; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; HUMANS; MICROFILAMENTS; PULMONARY ALVEOLI; VASCULAR ENDOTHELIAL GROWTH FACTOR A; X-RAY DIFFRACTION;

EID: 75549087019     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2008.10.002     Document Type: Article

References (39)

1. Adiseshaiah P., Lindner D.J., Kalvakolanu D.V., Reddy S.P. FRA-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo. Cancer Res 2007, 67:6204-6211.
2. Alvarez A.R., Godoy J.A., Mullendorff K., Olivares G.H., Bronfman M., Inestrosa N.C. Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons. Exp Cell Res 2004, 297:186-196.
3. Ashikaga T., Yoshida Y., Hirota M., Yoneyama K., Itagaki H., Sakaguchi H., et al. Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol. Toxicol in vitro 2006, 20:767-773.
4. Belluso E., Ferraris G. New data on balangeroite and carlosturanite from alpine serpentinites. Eur J Mineral 1991, 3:559-566.
5. Belluso E, Bellis D, Biagini G, Capella S, Fato R, Ferraris G, et al. Fibrous antigorite: multidisciplinary approach to a preliminary evaluation of cyto-toxicity meeting: From asbestos to nanoparticles: Past experience for future challenges and needs in particle toxicology, University of Torino, 28-30 June 2004, Book of Abstracts p. 21.
6. Bergamini C., Fato R., Biagini G., Pugnaloni A., Giantomassi F., Foresti E., et al. Mitochondrial changes induced by natural and synthetic asbestos fibers: Studies on isolated mitochondria. Cell Mol Biol 2007, 52(Suppl):OL905-OL913.
7. Blanco D., Vincet S., Elizegi E., Pino I., Fraga M.F., Esteller M., et al. Altered expression of adhesion molecules and epithelial mesenchymal transition in silica-induced rat lung carcinogenesis. Lab Invest 2004, 84:999-1012.
8. Boardman K.C., Aryal A.M., Miller W.M., Waters C.M. Actin re-distribution in response to hydrogen peroxide in airway epithelial cells. Cell Physiol 2004, 199:57-66.
9. Cardile V., Lombardo L., Belluso E., Panico A., Capella S., Balazy M. Toxicity and carcinogenicity mechanisms of fibrous antigorite. Int J Environ Res Public Health 2007, 4:1-9.
10. Comba P., Merler E., Pasetto R. Asbestos-related diseases in Italy: Epidemiologic evidences and public health issues. Int J Occup Environ Health 2005, 11:36-44.
11. Dumortier P., Rey F., Viallat J.R., Broucke I., Boutin C., De Vuyst P. Chrysotile and tremolite asbestos fibres in the lungs and parietal pleura of Corsican goats. Occup Environ Med 2002, 59:643-646.
12. Gazzano E., Turci F., Foresti E., Putzu M.G., Aldieri E., Silvagno F., et al. Iron-loaded synthetic chrysotile: A new model solid for studying the role of iron in asbestos toxicity. Chem Res Toxicol 2007, 20:380-387.
13. Gomes A., Fernandes E., Lima J.L. Fluorescence probes used for detection of reactive oxygen species. J Biochem Biophys Methods 2005, 65:45-80.
14. Hommura F., Furuuchi K., Yamazaki K., Ogura S., Kinoshita I., Shimizu M., et al. Increased expression of beta-catenin predicts better prognosis in non-small cell lung carcinomas. Cancer 2002, 4:752-758.
15. Ishii H., Yazawa T., Sato H., Suzuki T., Ikeda M., Hayashi Y., et al. Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs). Lung Cancer 2004, 45:325-337.
16. Kido T., Morimoto Y., Asonuma E., Yatera K., Ogami A., Oyabu T., et al. Chrysotile asbestos causes AEC apoptosis via the caspase activation in vitro and in vivo. Inhalation Toxicol 2008, 20:339-347.
17. Kusmartsev S., Gabrilovich D.I. Inhibition of myeloid cell differentiation in cancer: The role of reactive oxygen species. J Leukocyte Biol 2003, 74:186-196.
18. Liao X., Tang W., Cai Q., Li F., Zhigang F.U. Lymphangiogenesis in tumor tissues and 5′-Nase, Flt-4, Flk-1 expressions. Chin Med J 2000, 113:1031-1035.
19. Lindroos P.M., Coin P.G., Badgett A., Morgan D.L., Bonner J.G. Alveolar macrophages stimulated with titanium dioxide, chrysotile asbestos, and residual oil fly ash upregulate the PDGF receptor-alpha on lung fibroblasts through an IL-1beta-dependent mechanism. Am J Respir Cell Biol 1997, 16:283-292.
20. Mazieres J., He B., You L., Xu Z., Jablons D.M. Wnt signaling in lung cancer. Cancer Lett 2005, 222:1-10.
21. Myrvik Q.N., Knox E.A., Gordon M., Shirley P.S. Effects of asbestos on the random migration of rabbit alveolar macrophages. Environ Health Perspect 1985, 60:387-393.
22. Niklinski J., Niklinska W., Chyczewska E., Laudanski J., Naumnik W., Chyczewski L., et al. The epidemiology of asbestos-related diseases. Lung Cancer 2004, 45:S7-S15.
23. Oppenheimer S.B. Cellular basis of cancer metastasis: A review of fundamentals and new advances. Acta Histochem 2006, 108:327-334. [Review].
24. Panduri V., Surapureddi S., Soberanes S., Weitzman S.A., Chandel N., Kamp D.W. P53 mediates amosite asbestos-induced alveolar epithelial cell mitochondria-regulated apoptosis. Am J Respir Cell Mol Biol 2006, 34:443-452.
25. Peterson M.W., Kirschbaum J. Asbestos-induced lung epithelial permeability: Potential role of nonoxidant pathways. Am J Physiol 1998, 275:L262-L268.
26. Pugnaloni A., Lucarini G., Giantomassi F., Lombardo L., Capella S., Belluso E., et al. in vitro study of biofunctional indicators after exposure to asbestos-like fluoro-edenite fibres. Cell Mol Biol (Noisy-le-grand) 2007, 7:OL965-OL980.
27. Reinmuth N., Jauch A., Xu E.C., Muley T., Granzow M., Hoffmann H., et al. Correlation of EGFR mutations with chromosomal alterations and expression of EGFR, ErbB3 and VEGF in tumor samples of lung adenocarcinoma patients. Lung Cancer 2008, [Epub ahead of print].
28. Rubio L., Vera-Sempere F.J., Lopez-Guerrero J.A., Padilla J., Moreno-Baylach M.J. A risk model for non-small cell lung cancer using clinicopathological variables, angiogenesis and oncoprotein expression. Anticancer Res 2005, 25:497-504.
29. Sekine S., Shibata T., Matsuno Y., Maeshima A., Ishii G., Sakamoto M., et al. Beta-catenin mutations in pulmonary blastomas: Association with morule formation. J Pathol 2003, 200:214-221.
30. Shukla A., Gulumian M., Hei T.K., Kamp D., Rahman Q., Mossman B.T. Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free Radical Biol Med 2003, 34:1117-1129.
31. Shukla A., Ramos-Nino M., Mossman B. Cell signaling and transcription factor activation by asbestos in lung injury and disease. Int J Biochem Cell Biol 2003, 35:1198.
32. Trubiani O., Salvolini E., Staffolani R., Di Primio R., Mazzanti L. DMSO modifies structural and functional properties of RPMI-8402 cells by promoting programmed cell death. Int J Immunopathol Pharmacol 2003, 16:253-259.
33. Tucci M.G., Lucarini G., Brancorsini D., Zizzi A., Pugnaloni A., Giacchetti A., et al. Involvement of E-cadherin, beta-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma. Br J Dermatol 2007, 57:1212-1216.
34. van Dekken H., Wink J.C., Vissers K.J., Franken P.F., Ruud Schouten W.J., Hop W.C., et al. Wnt pathway-related gene expression during malignant progression in ulcerative colitis. Acta Histochem 2007, 109:266-272.
35. Wagner J.C., Sleggs C.A., Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 1960, 17:260-271.
36. Wang L.I., Neuberg D., Christiani D.C. Asbestos exposure, manganese superoxide dismutase (MnSOD) genotype and lung cancer risk. J Occup Environ Med 2004, 46:556-564.
37. Wicks FJ, O'Hanley DS. Serpentine minerals: Structures and petrology. In: Bailey SW, editor. Hydrous phyllosilicates (exclusive of micas). Rev Mineral. vol. 19: 1988; p. 91-167.
38. Wozniak H., Wiecek E., Stetkiewicz J. Fibrogenic and carcinogenic effects of antigorite. Pol J Occup Med 1988, 1:192-202.
39. Yao R., Wang Y., Lubet R.A., You M. Differentially expressed genes associated with mouse lung tumor progression. Oncogene 2002, 21:5814-5821.